Minimal/Measurable Residual Disease (MRD) Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptor

March 2nd, 2023

VIEW PUBLICATION ⟶

AUTHORS
Jack K. Tung / Diwash Jangam / Chandler C. Ho / Eula Fung / Michael S. Khodadoust / Youn H. Kim / James L. Zehnder / Henning Stehr / Bing M. Zhang